tirzepatide surmount 3 A 3-year study of in participants with obesity and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1 Nutritional status with tirzepatide in

Semaglutide activates the GLP-1 receptor, controlling blood sugar and reducing inflammation

The extent of skin laxity varies from person to person, depending on genetic factors, age, and the duration of weight gain prior to treatment

The news comes as new data on the valve's safety and effectiveness were just published in JACC: Cardiovascular Interventions

PlexusDx's Precision Peptide Genetic Test ($99 after month one) analyzes variants in GLP1R, FTO, MC4R, and GIPR genes to reveal how your body responds to GLP-1 agonists

Nature, 385, 214

2026: o Of outstanding importance o This study provides the first direct clinical evidence that LEAP2 infusion reduces food intake and improves postprandial glucose control in men living with obesity